C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome

• Auteurs principaux: Xueming Xu (Auteur), Jing Li (Auteur), Xiuyan Long (Auteur), Sifan Tao (Auteur), Xiaoyu Yu (Auteur), Xixian Ruan (Auteur), Kai Zhao (Auteur), Li Tian (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Numerous pieces of evidence have identified that the NLRP3 inflammasome plays a pivotal role in the development and pathogenesis of colitis. Targeting the NLRP3 inflammasome represents a potential therapeutic treatment. Our previous studies have suggested that acetylation of NLRP3 is indispensable t...